6/11/2014 6:38:12 AM
BOTHELL, Wash., June 11, 2014 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc., ("Alder") (Nasdaq:ALDR), a clinical-stage biopharmaceutical company developing therapeutic antibodies for the treatment of migraine, autoimmune and inflammatory diseases, today announced that members of Alder's senior management team will present at two upcoming conferences in June:
Help employers find you! Check out all the jobs and post your resume.
comments powered by